[Advances in immunotherapy for neuroendocrine neoplasms].

Zhang, P P; Lu, M; Shen, L

Zhang, P P; Lu, M; Shen, L.

Afiliación

Zhang PP; Department of Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Lu M; Department of Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Shen L; Department of Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

Zhonghua Wei Chang Wai Ke Za Zhi ; 24(10): 861-866, 2021 Oct 25.

Article en Zh | MEDLINE | ID: mdl-34674460

Asunto(s)

Neoplasias; Tumores Neuroendocrinos; Antígeno B7-H1; Biomarcadores de Tumor; Humanos; Inmunoterapia; Inestabilidad de Microsatélites; Tumores Neuroendocrinos/terapia

Palabras clave

Anti-angiogenic drugs; Biomarker; Immunotherapy; Neuroendocrine neoplasm

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Neoplasias Límite: Humans Idioma: Zh Revista: Zhonghua Wei Chang Wai Ke Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google